Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system, "the CNS"Two potent, selective, pre-clinical stage ...
Past research has shown that autism is often associated with an imbalance in two key neurotransmitters: GABA, which inhibits ...